Health Canada has approved the use of the abortion-inducing drug branded as Mifegymiso® in Canada.
Mifegymiso® provides a medical abortion regimen rather than a surgical procedure to induce an abortion. The treatment consists of a combination drug product of mifepristone and misoprostol. It is to be used sequentially for the termination of a developing intra-uterine pregnancy up to a gestational age of 49 days.